Home » EMA Updates Guideline on Clinical Investigations of VTE Products
EMA Updates Guideline on Clinical Investigations of VTE Products
June 7, 2012
The European Medicines Agency (EMA) has updated its draft guideline on clinical investigations of venous thromboembolism (VTE) products, adding new definitions for bleeding events and secondary endpoints to consider for clinical trials.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor